Acoramidis Has a Beneficial Effect Compared With Placebo on Change From Baseline in NAC ATTR Stage at Month 30 in Patients With ATTR-CM: Results From the ATTRibute-CM Study

Julian D. Gillmore, Martha Grogan, Timothy Sutton, Matthias Dupont, Nowell M. Fine, Kunal Bhatt, Diego Delgado, Chris Chen, Jean-François Tamby, Suresh Siddhanti, Jonathan C. Fox, Prem Soman, Marianna Fontana

Click the link below to download a PDF copy of this poster.

Gillmore J, et al. Presented at the Annual Scientific Session of the American Society of Nuclear Cardiology (ASNC), Sept 4-7, 2025, in Orlando, FL, USA.